## United States Environmental Protection Agency Washington, D.C. 20460

DATACALL-INRESPONSE INSTRUCTIONS: Please type or print in ink
. Please read carefully the attached instructions and supply the information requested on this form. Use additional sheet(s) ifnecessary. 

### Page 1 of 1 OMB Approval2070-174

1 . Company Name and Address 2. Case # and Name 

### 0643 Mancozeb 3. Date and Type of DCI and Number 

### 31-Jul-2007 GENERIC DOWAGROSCIENCES LLC 9330 ZIONSVILLE RD 308/2E INDIANAPOLIS, IN 462681054 Chemical#and Name 

### 014504 Mancozeb ID # GDCI-014504-26952 4
. EPA Product Registration



### 62719-387 62719-388 62719-396 62719-398 62719-401 62719-402 62719-418 62719-422 62719-423 62719-441 5
. Iwish to cancel this product registration voluntarily 6
. Generic Data 6a
. I am claiming a Generic Data Exemption because I obtain the active ingredient from the source EPA registration number listed below. 6b
. I agree to satisfy Generic Data requirements as indicated on the attached form entitled "Requirements Status and Registrant's Response."

I 7
. Product Specific Data 7a
. My product is an MUP and I agree to satisfythe MUP requirements on the attached form entitled "Requirements Status and Registrant's Response
." 

### N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A.

8
. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete
. I acknowledge that any knowingly false or misleading statement may be punishable byfine, imprisonment or both under applicable law. 9. Date Signature and Title ofCompany's Authorized Representative 10. Name ofCompany 11
. Phone Number 7b
. My product is an EUP and I agree to satisfythe EUP requirements on the attached form entitled "Requirements Status and Registrant's Response." 

### N.A. N.A. N.A. N
.A
. N.A. N.A. N.A. N.A. N.A. N.A.

### Page 1 of3 

## United StatesEnvironmental Protection OMB Approval 

### 2070-174 

## Agency Washington, D.C. 20460 REQUIREMENTS STATUSAND REGISTRANT'SRESPONSE INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form. Use additional sheet(s) if necessary. 

### 1. Company Name and Address 

### 2. Case 

### # and Name 

### 3. Date and Type of DCI and Number DOWAGROSCIENCES LLC 0643 

### Mancozeb 31-Jul-2007 9330 ZIONSVILLE RD 308/2E Chemical 

### # and Name 014504 GENERIC INDIANAPOLIS, IN 462681054 

### Mancozeb ID

### # GDCI-014504-26952 

### 4. Guideline p - 

### 5. Study Title R 

### Progress 6. Use 

### 7. Test 

### 8. Time 

### 9. Registrant Requirement 0 

### Reports Pattern Substance Frame Response Number T 

### (Months) 0 

## c 0 L 

### 1 2 3 Aggllcator Exgggure Dill Bggylrements (Conventlonj!l 

### .... ;. 

# - L ' 

### Chemical) 

### 875.1100 Dermal exposure-outdoor 

### (4 ,5 ,17) N 

### H, U, I, II, 

# a, A, 

### 8, C TEP

## ~4 875.1200 Dermal exposure-Indoor -**-=~** 

### (8 ,9 ,19) N 

### H, U, I, II, 

# a, A, 

### 8, C TEP 12 l 

### 875.1300 Inhalation exposure-outdoor (6 

### ,7 '18) N 

### H, U, I, II, 

# a, A, 

### 8, C TEP 24 

### 875.1400 Inhalation exposure-indoor 

### . 

## -. (21 ,22 ,23 N 

### H, U, I, II,

# a, A, 

### 8, C TEP 124 

### ,24) Nontarget Plant Protection Data Reguirements (Conventional Chemical) Terrestrial plant toxicity, Tier 

### 1 (seeding emergence) N 

### H, U, I, II,

# a, A, 

### 8, C TGAI 

### ' 12 

### 850.4100 

### ·-- 

## ' 850.4150 Terrestrial plant toxicity, Tier 

### 1 (vegetative vigor) N 

### H, U, I, II, 

# a, A, 

### 8, C TGAI 12



# . Aquatic planttoxicity test using Lemna spp.Tiers I 

### (16) 

# ' .. H, U, I, II, 

# a, A, 

### 8, C 

### Met 

### - - 

## 12 850.4400 N 

# . and II ProductChemist[ll Data Reguirements (Conventional Chemical) UVNisible absorption -· .**·-~-** 

### H. U, I, II, 

# a, A, 

### 8, C PAI;TGAI 

## "

## ~ 830.7050 l 

### .. 

## ' N 

## : ' '· 

### Residue Chemist[ll Data Reguirements for Food Uses (Conventional Chemicil) 

### 10. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete
. I acknowledge that any 

### 11 . Date I 

### knowingly false or misleading statement may 

### be punishable by fine, imprisonment or both under applicable law Signature and Title ofCompany's Authorized Representative 

### 12. Name ofCompany 

### 13. Phone Number

------ - L
_____ ----

## United States Environmental Protection Agency Washington, D.C. 20460 REQUIREMENTS STATUSAND REGISTRANT'SRESPONSE INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form. Use additional sheet(s) 

### ifnecessary. 

### Page 3 of3 OMB Approva12070·174



### 1. Company Name and Address 

### 2. Case

### # and Name 3. Date and Type of DCI and Number 

### DOWAGROSCIENCES LLC 9330 ZIONSVILLE RD 308/2E INDIANAPOLIS, IN 462681054 4. Guideline Requirement Number

ssct1 

### 5. StudyTitle

Comparative thyroid toxicity study

Initial to indicate certification as to information on this page (full text ofcertification is on page one). 

### 0643 Mancozeb Chemical

### # and Name 

### Mancozeb p 

### R 0 T 0 

## c 0

# (~~ 014504
Progress Reports


### 1 I 2 I 3 6. Use Pattern



### H, U, I, II, Q, 

### A, B, C 31-Jul-2007 GENERIC ID

### # GDCI-014504-26952 7. Test Substance



### Met

Date 

### 8. Time Frame (Months) 

# j24 9. Registrant Response

## United States Environmental Protection Agency Washington, D.C. 20460 FOOTNOTESAND KEYDEFINITIONSFORGUIDELINEREQUIREMENTS Case#andName: DCINumber: 0643 Mancozeb GDCI-014504-26952 Page 1 of2

Key: PAl; TGAI 

### = Pure Active ingredient, Technical Grade ofthe Active Ingredient; TEP 

### =Typical End Use Product [TEP]; TGAI 

### =Technical GradeActive Ingredient [TGAI]; Residue ofConcern 

### = Residue ofConcern; Met 

### =Metabolite

Use Categories Key: A- Terrestrial food crop B- Terrestrial feed crop C- Terrestrial nonfood crop 

### HI-QGreenhouse food crop Greenhouse nonfood crop Residential outdoor use 

### U

### 11
- Residential and public access p Residential Use Conventional C 

## Footnotes: [The following notes are referenced In column two (5. Study File) ofthe REQUIREMENTS STATUS AND REGISTRANTS RESPONSE form.] 1 An information-based approach to testing is preferred, which utilizes the best available knowledge on the chemical (hazard, pharmacokinetic, or mechanistic data) to determine whether a standard guideline study, an enhanced guideline study, oran alternative study should be conducted to assess potential hazard to the developing animal, or in some cases to support awaiver for such testing. Registrants should submit any alternative proposed testing protocols and supporting scientific rationale to the Agency priorto study initiation. 2 The use ofa combined study that utilizes the two-generation reproduction study in rodents (870.3800) as a basic protocol for the addition ofother endpoints orfunctional assessments in the immature animal is encouraged. 3 May be combined with the two-generation reproduction study in rodents (870.3800) by utilizing a second mating ofthe parental animals in either generation
. The dams are to undergo a cesarean section at one day priorto expected delivery date and evaluated separately as specified in guideline 870
.3700. 4 Biological monitoring data may be submitted in addition to, or in lieu of, dermal and inhalation exposure data, provided the human pharmacokinetics ofthe pesticide and/or metabolite/analog compounds (i.e., whichever method is selected as an indicator ofbody burden or internal dose) allowforthe back calculation to actual dose. 5 Protocols must be submitted for approval priorto the initiation ofthe study
. Details for developing protocols are available from the Agency. 6 Biological monitoring data may be submitted in addition to, or in lieu of, dermal and inhalation exposure data, provided the human pharmacokinetics ofthe pesticide and/or metabolite/analog compounds (i.e., whichever method is selected as an indicatorofbody burden or internal dose) allow for the back calculation to actual dose. 7 Protocols must be submitted for approval priorto the initiation ofthe study. Details for developing protocols are available from the Agency
. 8 Biological monitoring data may be submitted in addition to, or in lieu of, dermal and inhalation exposure data, provided the human pharmacokinetics ofthe pesticide and/or metabolite/analog compounds (i.e., whichever method is selected as an indicator of body burden or internal dose) allow for the back calculation to actual dose. 9 Protocols must 

### besubmitted for approval priorto the initiation ofthe study. Details for developing protocols are available from the Agency. 10 A residue analytical method suitable for enforcement purposes is required whenever a numeric tolerance (including temporary and time-limited tolerance) is proposed, and may 

### be required for a tolerance exemption. 11 New analytical methods to be used for enforcement purposes must include results from an independent laboratory validation. 12 Study is required for the ETU metabolite/degradate. 13 Test protocol must be submitted to & approved by EPAbefore study is initiated. 14 Protocol must be submitted to & approved by EPA before study is initiated.

### Co. Nr. 62719 4581 352 

## United States Environmental Protection Agency Washington, D.C. 20460 LIST OFALLREGISTRANTS SENTTHISDATA CALL-INNOTICE

Case

### # and Name: 0643,Mancozeb Company Name DOWAGROSCIENCES LLC CEREXAGRI, INC. E
. 

### I. DU PONT DE NEMOURS AND COMPANY (S300/419) Agent For Address City & State Zip 9330 ZIONSVILLE RD 308/2E INDIANAPOLIS IN 462681054 630 FREEDOM BUSINESS CENTER, SUITE 402 KING OF PRUSSIA PA 19406 1007 MARKET STREET WILMINGTON DE 198980001